Marvel Biosciences Corp.
MBCOF
$0.0629
-$0.0021-3.23%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -90.48% | -73.79% | -40.86% | -78.57% | 93.03% |
| Total Receivables | 21.85% | 34.33% | 34.67% | 53.42% | 67.04% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.69% | -18.78% | -16.73% | -9.14% | 11.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -71.52% | -47.57% | -30.42% | -71.92% | 10.91% |
|
|
|||||
| Total Current Assets | -71.52% | -47.57% | -30.42% | -71.92% | 10.91% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -71.52% | -47.57% | -30.42% | -71.92% | 10.91% |
|
|
|||||
| Total Accounts Payable | 7.30% | -12.21% | 6.22% | 384.46% | 603.76% |
| Total Accrued Expenses | 77.27% | 86.26% | 34.17% | -68.04% | -59.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.10% | -4.06% | 9.91% | 75.87% | 165.97% |
|
|
|||||
| Total Current Liabilities | 14.10% | -4.06% | 9.91% | 75.87% | 165.97% |
| Long-Term Debt | 5.38% | 70.43% | 62.84% | 74.37% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.97% | 23.91% | 32.03% | 75.14% | 405.47% |
|
|
|||||
| Common Stock & APIC | -4.58% | 2.93% | 1.27% | -2.97% | 0.28% |
| Retained Earnings | -8.12% | -14.36% | -12.59% | -24.61% | -34.07% |
| Treasury Stock & Other | -- | -- | 38.78% | -- | -- |
| Total Common Equity | -33.58% | -37.85% | -56.45% | -414.67% | -16,480.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.58% | -37.85% | -56.45% | -414.67% | -16,480.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.58% | -37.85% | -56.45% | -414.67% | -16,480.36% |
|
|
|||||